Potential usefulness of DNA methylation as a risk marker for digestive cancer associated with inflammation

References

• Ushijima T, Watanabe N, Okochi E, Kaneda A, Sugimura T, Miyamoto K. Fidelity of the methylation pattern and its variation in the genome. Genome Res.13(5), 868–874 (2003).
   PubMed Web of Science ®Google Scholar
• Riggs AD, Xiong Z. Methylation and epigenetic fidelity. Proc. Natl Acad. Sci. USA101(1), 4–5 (2004).
   PubMed Web of Science ®Google Scholar
• Fazzari MJ, Greally JM. Introduction to epigenomics and epigenome-wide analysis. Methods Mol. Biol.620, 243–265 (2010).
   PubMedGoogle Scholar
• Kondo Y. Epigenetic cross-talk between DNA methylation and histone modifications in human cancers. Yonsei Med. J.50(4), 455–463 (2009).
   PubMed Web of Science ®Google Scholar
• Jones PA, Baylin SB. The epigenomics of cancer. Cell128(4), 683–692 (2007).
   PubMed Web of Science ®Google Scholar
• Toyota M, Issa JP. Epigenetic changes in solid and hematopoietic tumors. Semin. Oncol.32(5), 521–530 (2005).
   PubMed Web of Science ®Google Scholar
• Ushijima T, Okochi-Takada E. Aberrant methylations in cancer cells: where do they come from? Cancer Sci.96(4), 206–211 (2005).
   PubMed Web of Science ®Google Scholar
• Suzuki H, Tokino T, Shinomura Y, Imai K, Toyota M. DNA methylation and cancer pathways in gastrointestinal tumors. Pharmacogenomics9(12), 1917–1928 (2008).
   PubMed Web of Science ®Google Scholar
• Ushijima T. Detection and interpretation of altered methylation patterns in cancer cells. Nat. Rev. Cancer5(3), 223–231 (2005).
   PubMed Web of Science ®Google Scholar
• Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, Issa JP. CpG island methylator phenotype in colorectal cancer. Proc. Natl Acad. Sci. USA96(15), 8681–8686 (1999).
   PubMed Web of Science ®Google Scholar
• Toyota M, Ahuja N, Suzuki H et al. Aberrant methylation in gastric cancer associated with the CpG island methylator phenotype. Cancer Res.59(21), 5438–5442 (1999).
   PubMed Web of Science ®Google Scholar
• Toyota M, Ohe-Toyota M, Ahuja N, Issa JP. Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Proc. Natl Acad. Sci. USA97(2), 710–715 (2000).
   PubMed Web of Science ®Google Scholar
• Kusano M, Toyota M, Suzuki H et al. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein–Barr virus. Cancer106(7), 1467–1479 (2006).
   PubMed Web of Science ®Google Scholar
• Ahn JB, Chung WB, Maeda O et al. DNA methylation predicts recurrence from resected stage III proximal colon cancer. Cancer117(9), 1847–1854 (2011).
   PubMed Web of Science ®Google Scholar
• Jover R, Nguyen TP, Pérez-Carbonell L et al. 5-Fluorouracil adjuvant chemotherapy does not increase survival in patients with CpG island methylator phenotype colorectal cancer. Gastroenterology140(4), 1174–1181 (2011).
   PubMed Web of Science ®Google Scholar
• Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat. Genet.7(4), 536–540 (1994).
   PubMed Web of Science ®Google Scholar
• Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res.58(23), 5489–5494 (1998).
   PubMed Web of Science ®Google Scholar
• Kwabi-Addo B, Chung W, Shen L et al. Age-related DNA methylation changes in normal human prostate tissues. Clin. Cancer Res.13(13), 3796–3802 (2007).
   PubMed Web of Science ®Google Scholar
• Uemura N, Okamoto S, Yamamoto S et al. Helicobacter pylori infection and the development of gastric cancer. N. Engl. J. Med.345(11), 784–789 (2001).
   PubMed Web of Science ®Google Scholar
• Ekbom A, Helmick C, Zack M, Adami HO. Ulcerative colitis and colorectal cancer. A population-based study. N. Engl. J. Med.323(18), 1228–1233 (1990).
   PubMed Web of Science ®Google Scholar
• Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut48(4), 526–535 (2001).
   PubMed Web of Science ®Google Scholar
• Llovet JM, Bruix J. Novel advancements in the management of hepatocellular carcinoma in 2008. J. Hepatol.48(Suppl. 1), S20–S37 (2008).
   PubMed Web of Science ®Google Scholar
• Nakajima T, Maekita T, Oda I et al. Higher methylation levels in gastric mucosae significantly correlate with higher risk of gastric cancers. Cancer Epidemiol.Biomarkers Prev.15(11), 2317–2321 (2006).
   PubMed Web of Science ®Google Scholar
• Tahara T, Shibata T, Nakamura M et al. Increased number of CpG island hypermethylation in tumor suppressor genes of non-neoplastic gastric mucosa correlates with higher risk of gastric cancer. Digestion82(1), 27–36 (2010).
   PubMed Web of Science ®Google Scholar
• Issa JP, Ahuja N, Toyota M, Bronner MP, Brentnall TA. Accelerated age-related CpG island methylation in ulcerative colitis. Cancer Res.61(9), 3573–3577 (2001).
   PubMed Web of Science ®Google Scholar
• Nishida N, Nagasaka T, Nishimura T, Ikai I, Boland CR, Goel A. Aberrant methylation of multiple tumor suppressor genes in aging liver, chronic hepatitis, and hepatocellular carcinoma. Hepatology47(3), 908–918 (2008).
   PubMed Web of Science ®Google Scholar
• Laird PW. The power and the promise of DNA methylation markers. Nat. Rev. Cancer3(4), 253–266 (2003).
   PubMed Web of Science ®Google Scholar
• No authors listed. NIH Consensus Conference. Helicobacter pylori in peptic ulcer disease. NIH Consensus Development Panel on Helicobacter pylori in Peptic Ulcer Disease. JAMA272(1), 65–69 (1994).
   PubMed Web of Science ®Google Scholar
• Parsonnet J, Friedman GD, Vandersteen DP et al.Helicobacter pylori infection and the risk of gastric carcinoma. N. Engl. J. Med.325(16), 1127–1131 (1991).
   PubMed Web of Science ®Google Scholar
• Huang JQ, Sridhar S, Chen Y et al. Meta-analysis of the relationship between Helicobacter pylori seropositivity and gastric cancer. Gastroenterology114(6), 1169–1179 (1998).
   PubMed Web of Science ®Google Scholar
• Blaser MJ, Parsonnet J. Parasitism by the ‘slow’ bacterium Helicobacter pylori leads to altered gastric homeostasis and neoplasia. J. Clin. Invest.94(1), 4–8 (1994).
   PubMed Web of Science ®Google Scholar
• Uemura N, Mukai T, Okamoto S et al. Effect of Helicobacter pylori eradication on subsequent development of cancer after endoscopic resection of early gastric cancer. Cancer Epidemiol.Biomarkers Prev.6(8), 639–642 (1997).
   PubMed Web of Science ®Google Scholar
• Wong BC, Lam SK, Wong WM et al. China Gastric Cancer Study Group. Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA291(2), 187–194 (2004).
   PubMed Web of Science ®Google Scholar
• Hosokawa O, Tsuda S, Kidani E et al. Diagnosis of gastric cancer up to three years after negative upper gastrointestinal endoscopy. Endoscopy30(8), 721–773 (1998).
   PubMed Web of Science ®Google Scholar
• Wang M, Furuta T, Takashima M et al. Relation between interleukin-1β messenger RNA in gastric fundic mucosa and gastric juice pH in patients infected with Helicobacter pylori. J. Gastroenterol.34(Suppl. 11), 10–17 (1999).
   PubMed Web of Science ®Google Scholar
• Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J. Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut41(4), 442–451 (1997).
   PubMed Web of Science ®Google Scholar
• Tamura G. Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J. Gastroenterol.12(2), 192–198 (2006).
   PubMed Web of Science ®Google Scholar
• Kang GH, Shim YH, Jung HY, Kim WH, Ro JY, Rhyu MG. CpG island methylation in premalignant stages of gastric carcinoma. Cancer Res.61(7), 2847–2851 (2001).
   PubMed Web of Science ®Google Scholar
• Kang GH, Lee HJ, Hwang KS, Lee S, Kim JH, Kim JS. Aberrant CpG island hypermethylation of chronic gastritis, in relation to aging, gender, intestinal metaplasia, and chronic inflammation. Am. J. Pathol.163(4), 1551–1556 (2003).
   PubMed Web of Science ®Google Scholar
• Maekita T, Nakazawa K, Mihara M et al. High levels of aberrant DNA methylation in Helicobacter pylori-infected gastric mucosae and its possible association with gastric cancer risk. Clin. Cancer. Res.12(3 Pt 1), 989–995 (2006).
   PubMed Web of Science ®Google Scholar
• Tahara T, Arisawa T, Shibata T et al. Increased number of methylated CpG islands correlates with Helicobacter pylori infection, histological and serological severity of chronic gastritis. Eur. J. Gastroenterol. Hepatol.21(6), 613–619 (2009).
   PubMed Web of Science ®Google Scholar
• Kaise M, Yamasaki T, Yonezawa J, Miwa J, Ohta Y, Tajiri H. CpG island hypermethylation of tumor-suppressor genes in H. pylori-infected non-neoplastic gastric mucosa is linked with gastric cancer risk. Helicobacter13(1), 35–41 (2008).
   PubMedGoogle Scholar
• Yamamoto E, Toyota M, Suzuki H et al. LINE-1 hypomethylation is associated with increased CpG island methylation in Helicobacter pylori-related enlarged-fold gastritis. Cancer Epidemiol. Biomarkers Prev.17(10), 2555–2564 (2008).
   PubMed Web of Science ®Google Scholar
• Nakajima T, Enomoto S, Yamashita S et al. Persistence of a component of DNA methylation in gastric mucosae after Helicobacter pylori eradication. J. Gastroenterol.45(1), 37–44 (2010).
   PubMed Web of Science ®Google Scholar
• Head KA, Jurenka JS. Inflammatory bowel disease part I: ulcerative colitis – pathophysiology and conventional and alternative treatment options. Altern. Med. Rev.8(3), 247–283 (2003).
   PubMedGoogle Scholar
• Askling J, Dickman PW, Karlen P et al. Family history as a risk factor for colorectal cancer in inflammatory bowel disease. Gastroenterology120(6), 1356–1362 (2001).
   PubMed Web of Science ®Google Scholar
• Nuako KW, Ahlquist DA, Mahoney DW et al. Familial predisposition for colorectal cancer in chronic ulcerative colitis: a case–control study. Gastroenterology115(5), 1079–1083 (1998).
   PubMed Web of Science ®Google Scholar
• Jayaram H, Satsangi J, Chapman RW. Increased colorectal neoplasia in chronic ulcerative colitis complicated by primary sclerosing cholangitis: fact or fiction? Gut48(3), 430–434 (2001).
   PubMed Web of Science ®Google Scholar
• Rutter MD, Saunders BP, Wilkinson KH et al. Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk. Gut53(12), 1813–1816 (2004).
   PubMed Web of Science ®Google Scholar
• Hsieh CJ, Klump B, Holzmann K, Borchard F, Gregor M, Porschen R. Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res.58(17), 3942–3945 (1998).
   PubMed Web of Science ®Google Scholar
• Fleisher AS, Esteller M, Harpaz N et al. Microsatellite instability in inflammatory bowel disease-associated neoplastic lesions is associated with hypermethylation and diminished expression of the DNA mismatch repair gene, hMLH1. Cancer Res.60(17), 4864–4868 (2000).
   PubMed Web of Science ®Google Scholar
• Itzkowitz SH, Yio X. Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am. J. Physiol. Gastrointest. Liver Physiol.287(1), G7–G17 (2004).
   PubMed Web of Science ®Google Scholar
• Rutter M, Saunders B, Wilkinson K et al. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology126(2), 451–459 (2004).
   PubMed Web of Science ®Google Scholar
• Moriyama T, Matsumoto T, Nakamura S et al. Hypermethylation of p14 (ARF) may be predictive of colitic cancer in patients with ulcerative colitis. Dis. Colon. Rectum50(9), 1384–1392 (2007).
   PubMed Web of Science ®Google Scholar
• Wang FY, Arisawa T, Tahara T et al. Aberrant DNA methylation in ulcerative colitis without neoplasia. Hepatogastroenterology55(81), 62–65 (2008).
   PubMedGoogle Scholar
• Cho JH, Brant SR. Recent insights into the genetics of inflammatory bowel disease. Gastroenterology140(6), 1704–1712 (2011).
   PubMed Web of Science ®Google Scholar
• Thompson AI, Lees CW. Genetics of ulcerative colitis. Inflamm. Bowel Dis.17(3), 831–848 (2011).
   PubMed Web of Science ®Google Scholar
• Di Girolamo N, Visvanathan K, Lloyd A, Wakefield D. Expression of TNFα by human plasma cells in chronic inflammation. J. Leukoc. Biol.61(6), 667–678 (1997).
   PubMed Web of Science ®Google Scholar
• Noguchi M, Hiwatashi N, Liu Z, Toyota T. Secretion imbalance between tumour necrosis factor and its inhibitor in inflammatory bowel disease. Gut43(2), 203–209 (1998).
   PubMed Web of Science ®Google Scholar
• Huang S, Ullrich SE, Bar-Eli M. Regulation of tumor growth and metastasis by interleukin-10: the melanoma experience. J. Interferon Cytokine Res.19(7), 697–703 (1999).
   PubMed Web of Science ®Google Scholar
• Zimmerman NP, Vongsa RA, Wendt MK, Dwinell MB. Chemokines and chemokine receptors in mucosal homeostasis at the intestinal epithelial barrier in inflammatory bowel disease. Inflamm. Bowel Dis.14(7), 1000–1011 (2008).
   PubMed Web of Science ®Google Scholar
• Bollrath J, Phesse TJ, von Burstin VA et al. gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell15(2), 91–102 (2009).
   PubMed Web of Science ®Google Scholar
• Grivennikov S, Karin E, Terzic J et al. IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell15(2), 103–113 (2009).
   PubMed Web of Science ®Google Scholar
• Konishi K, Shen L, Wang S, Meltzer SJ, Harpaz N, Issa JP. Rare CpG island methylator phenotype in ulcerative colitis-associated neoplasias. Gastroenterology132(4), 1254–1260 (2007).
   PubMed Web of Science ®Google Scholar
• Fujii S, Tominaga K, Kitajima K et al. Methylation of the oestrogen receptor gene in non-neoplastic epithelium as a marker of colorectal neoplasia risk in longstanding and extensive ulcerative colitis. Gut54(9), 1287–1292 (2005).
   PubMed Web of Science ®Google Scholar
• Tominaga K, Fujii S, Mukawa K et al. Prediction of colorectal neoplasia by quantitative methylation analysis of estrogen receptor gene in nonneoplastic epithelium from patients with ulcerative colitis. Clin. Cancer Res.11(24 Pt 1), 8880–8885 (2005).
   PubMed Web of Science ®Google Scholar
• Garrity-Park MM, Loftus EV Jr, Sandborn WJ, Bryant SC, Smyrk TC. Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer. Am. J. Gastroenterol.105(7), 1610–1619 (2010).
   PubMed Web of Science ®Google Scholar
• Saito S, Kato J, Hiraoka S et al. DNA methylation of colon mucosa in ulcerative colitis patients: correlation with inflammatory status. Inflamm. Bowel Dis.17(9), 1955–1965 (2011).
   PubMed Web of Science ®Google Scholar
• Tahara T, Shibata T, Nakamura M et al. Effect of MDR1 gene promoter methylation in patients with ulcerative colitis. Int. J. Mol. Med.23(4), 521–527 (2009).
   PubMed Web of Science ®Google Scholar
• Tahara T, Shibata T, Nakamura M et al. Promoter methylation of protease-activated receptor (PAR2) is associated with severe clinical phenotypes of ulcerative colitis (UC). Clin. Exp. Med.9(2), 125–130 (2009).
   PubMed Web of Science ®Google Scholar
• Neumann H, Vieth M, Langner C, Neurath MF, Mudter J. Cancer risk in IBD: how to diagnose and how to manage DALM and ALM. World J. Gastroenterol.17(27), 3184–3191 (2011).
   PubMed Web of Science ®Google Scholar
• Feitelson MA. Parallel epigenetic and genetic changes in the pathogenesis of hepatitis virus-associated hepatocellular carcinoma. Cancer Lett.239(1), 10–20 (2006).
   PubMed Web of Science ®Google Scholar
• Kondoh N, Wakatsuki T, Hada A et al. Genetic and epigenetic events in human hepatocarcinogenesis. Int. J. Oncol.18(6), 1271–1278 (2001).
   PubMed Web of Science ®Google Scholar
• Boyault S, Rickman DS, De Reynies A et al. Transcriptome classification of HCC is related to gene alterations and to new therapeutic targets. Hepatology45(1), 42–52 (2007).
   PubMed Web of Science ®Google Scholar
• Wong IH, Lo YM, Zhang J et al. Detection of aberrant p16 methylation in the plasma and serum of liver cancer patients. Cancer Res.59(1), 71–73 (1999).
   PubMed Web of Science ®Google Scholar
• Zhang YJ, Ahsan H, Chen Y et al. High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1-DNA adduct levels in human hepatocellular carcinoma. Mol. Carcinog.35(2), 85–92 (2002).
   PubMed Web of Science ®Google Scholar
• Xiao WH, Liu WW. Hemizygous deletion and hypermethylation of RUNX3 gene in hepatocellular carcinoma. World J. Gastroenterol.10(3), 376–380 (2004).
   PubMed Web of Science ®Google Scholar
• Kanai Y, Ushijima S, Hui AM et al. The E-cadherin gene is silenced by CpG methylation in human hepatocellular carcinomas. Int. J. Cancer71(3), 355–359 (1997).
   PubMed Web of Science ®Google Scholar
• Zhong S, Tang MW, Yeo W, Liu C, Lo YM, Johnson PJ. Silencing of GSTP1 gene by CpG island DNA hypermethylation in HBV-associated hepatocellular carcinomas. Clin. Cancer Res.8(4), 1087–1092 (2002).
   PubMed Web of Science ®Google Scholar
• Yang B, Guo M, Herman JG, Clark DP. Aberrant promoter methylation profiles of tumor suppressor genes in hepatocellular carcinoma. Am. J. Pathol.163(3), 1101–1107 (2003).
   PubMed Web of Science ®Google Scholar
• Shen L, Ahuja N, Shen Y et al. DNA methylation and environ mental exposures in human hepatocellular carcinoma. J. Natl Cancer Inst.94(10), 755–761 (2002).
   PubMedGoogle Scholar
• Iwata N, Yamamoto H, Sasaki S et al. Frequent hypermethylation of CpG islands and loss of expression of the 14–3–3 σ gene in human hepatocellular carcinoma. Oncogene19(46), 5298–5302 (2000).
   PubMed Web of Science ®Google Scholar
• Kaneto H, Sasaki S, Yamamoto H et al. Detection of hypermethylation of the p16 (INK4A) gene promoter in chronic hepatitis and cirrhosis associated with hepatitis B or C virus. Gut48(3), 372–377 (2001).
   PubMed Web of Science ®Google Scholar
• Saito Y, Kanai Y, Sakamoto M, Saito H, Ishii H, Hirohashi S. Expression of mRNA for DNA methyltransferases and methyl-CpG-binding proteins and DNA methylation status on CpG islands and pericentromeric satellite regions during human hepatocarcinogenesis. Hepatology33(3), 561–568 (2001).
   PubMed Web of Science ®Google Scholar
• Su PF, Lee TC, Lin PJ et al. Differential DNA methylation associated with hepatitis B virus infection in hepatocellular carcinoma. Int. J. Cancer121(6), 1257–1264 (2007).
   PubMed Web of Science ®Google Scholar
• Jicai Z, Zongtao Y, Jun L, Haiping L, Jianmin W, Lihua H. Persistent infection of hepatitis B virus is involved in high rate of p16 methylation in hepatocellular carcinoma. Mol. Carcinog.45(7), 530–536 (2006).
   PubMed Web of Science ®Google Scholar
• Park IY, Sohn BH, Yu E et al. Aberrant epigenetic modifications in hepatocarcinogenesis induced by hepatitis B virus X protein. Gastroenterology132(4), 1476–1494 (2007).
   PubMed Web of Science ®Google Scholar
• Deng YB, Nagae G, Midorikawa Y et al. Identification of genes preferentially methylated in hepatitis C virus-related hepatocellular carcinoma. Cancer Sci.101(6), 1501–1510 (2010).
   PubMed Web of Science ®Google Scholar
• Lim SO, Gu JM, Kim MS et al. Epigenetic changes induced by reactive oxygen species in hepatocellular carcinoma: methylation of the E-cadherin promoter. Gastroenterology135(6), 2128–2140 (2008).
   PubMed Web of Science ®Google Scholar
• Hartnett L, Egan LJ. Inflammation, DNA methylation and colitis-associated cancer. Carcinogenesis33(4), 723–731 (2012).
   PubMed Web of Science ®Google Scholar
• Ushijima T. Epigenetic field for cancerization. J. Biochem. Mol. Biol.40(2), 142–150 (2007).
   PubMedGoogle Scholar
• Colella S, Shen L, Baggerly KA, Issa JP, Krahe R. Sensitive and quantitative universal pyrosequencing methylation analysis of CpG sites. Biotechniques35(1), 146–150 (2003).
   PubMed Web of Science ®Google Scholar
• Watanabe Y, Kim HS, Castoro RJ et al. Sensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washes. Gastroenterology136(7), 2149–2158 (2009).
   PubMed Web of Science ®Google Scholar
• Kamimae S, Yamamoto E, Yamano HO et al. Epigenetic alteration of DNA in mucosal wash fluid predicts invasiveness of colorectal tumors. Cancer Prev. Res. (Phila.)4(5), 674–683 (2011).
   PubMed Web of Science ®Google Scholar
• Shin CM, Kim N, Jung Y et al. Genome-wide DNA methylation profiles in noncancerous gastric mucosae with regard to Helicobacter pylori infection and the presence of gastric cancer. Helicobacter16(3), 179–188 (2011).
   PubMed Web of Science ®Google Scholar
• Matsusaka K, Kaneda A, Nagae G et al. Classification of Epstein–Barr virus-positive gastric cancers by definition of DNA methylation epigenotypes. Cancer Res.71(23), 7187–7197 (2011).
   PubMed Web of Science ®Google Scholar
• Ando T, Yoshida T, Enomoto S et al. DNA methylation of microRNA genes in gastric mucosae of gastric cancer patients: its possible involvement in the formation of epigenetic field defect. Int. J. Cancer124(10), 2367–2374 (2009).
   PubMed Web of Science ®Google Scholar
• Suzuki H, Yamamoto E, Nojima M et al. Methylation-associated silencing of microRNA-34b/c in gastric cancer and its involvement in an epigenetic field defect. Carcinogenesis31(12), 2066–2073 (2010).
   PubMed Web of Science ®Google Scholar